SmallCapVoice: PositiveID Corp. (PSID) Announces Initiation of Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device
PositiveID Corp., a developer of medical technologies for diabetes management, announced today that it has commenced a clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes. The clinical trial, being held at Schneider Children’s Medical Center in Israel, a preeminent research hospital, will initially focus on people with type 1 diabetes and the Company expects to begin recruiting subjects this month. Currently under development in Israel, Easy Check is a non-invasive breath glucose detection device that measures the level of acetone in a patient’s exhaled breath and correlates that acetone level to a measure…